AAAAAA

   
Results: 1-9 |
Results: 9
Fibrovascular polyp of the esophagus - diagnosis and therapy
Authors: Weiand, G Knipping, L Mangold, G
Citation: G. Weiand et al., Fibrovascular polyp of the esophagus - diagnosis and therapy, CHIRURG, 72(7), 2001, pp. 847-852
Single arterial vessel injury of the calf
Authors: Riemer, A Knipping, L Mangold, G
Citation: A. Riemer et al., Single arterial vessel injury of the calf, CHIRURG, 72(3), 2001, pp. 281-285
Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model
Authors: Hammond, LA Hilsenbeck, SG Eckhardt, SG Marty, J Mangold, G MacDonald, JR Rowinsky, EK Von Hoff, DD Weitman, S
Citation: La. Hammond et al., Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model, EUR J CANC, 36(18), 2000, pp. 2430-2436
Ruptured pancreaticoduodenal artery aneurysm - a rare cause of acute abdomen
Authors: Knipping, L Riemer, A Weiand, G Mangold, G
Citation: L. Knipping et al., Ruptured pancreaticoduodenal artery aneurysm - a rare cause of acute abdomen, CHIRURG, 71(10), 2000, pp. 1285-1287
Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograft
Authors: Weitman, S Mangold, G Marty, J Dexter, D Hilsenbeck, S Rake, J Juniewicz, P Von Hoff, D
Citation: S. Weitman et al., Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograft, CANC CHEMOT, 43(5), 1999, pp. 402-408
Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model
Authors: Britten, CD Hilsenbeck, SG Eckhardt, SG Marty, J Mangold, G MacDonald, JR Rowinsky, EK Von Hoff, DD Weitman, S
Citation: Cd. Britten et al., Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model, CANCER RES, 59(5), 1999, pp. 1049-1053
Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts
Authors: Wadkins, RM Potter, PM Vladu, B Marty, J Mangold, G Weitman, S Manikumar, G Wani, MC Wall, ME Von Hoff, DD
Citation: Rm. Wadkins et al., Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts, CANCER RES, 59(14), 1999, pp. 3424-3428
A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay
Authors: Raymond, E Sun, D Izbicka, E Mangold, G Silvas, E Windle, B Sharma, S Soda, H Laurence, R Davidson, K Von Hoff, DD
Citation: E. Raymond et al., A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay, BR J CANC, 80(9), 1999, pp. 1332-1341
Transgenic mice with pigmented intraocular tumors: Tissue of origin and treatment
Authors: Syed, NA Windle, JJ Darjatmoko, SR Lokken, JM Steeves, RA Chappell, R Wallow, IHL Koop, BA Mangold, G Howes, KA Albert, DM
Citation: Na. Syed et al., Transgenic mice with pigmented intraocular tumors: Tissue of origin and treatment, INV OPHTH V, 39(13), 1998, pp. 2800-2805
Risultati: 1-9 |